Werewolf Therapeutics Operating Cycle Over Time

HOWL Stock  USD 0.61  0.03  4.69%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Werewolf Therapeutics Performance and Werewolf Therapeutics Correlation.
For more information on how to buy Werewolf Stock please use our How to buy in Werewolf Stock guide.The value of Operating Cycle is estimated to slide to 26.99.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Werewolf Therapeutics. Market participants price Werewolf higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Werewolf Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(1.62)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.41)
Return On Equity
(1.22)
Investors evaluate Werewolf Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Werewolf Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Werewolf Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Werewolf Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Werewolf Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Werewolf Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.
Specify up to 10 symbols:

Cross Equities Operating Cycle Analysis

Compare Werewolf Therapeutics and related stocks such as IO Biotech, Spruce Biosciences Common, and OUTLOOK THERAPEUTICS INC Operating Cycle Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
20102011201220132014201520162017201820192020202120222023202420252026
IOBT0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
SPRB0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
OTLK173173173173301898898898898898898898898898898809849
ACET88.799314714218120419934334334334355.67878.02776.35356.35356.35357.316.94
NRXP0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
LITS79.53379.53379.53379.53379.53379.53379.53379.53379.53379.53379.53390.08180.63550.63550.63550.730.69
OSTX0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
CUE19619619619619619619619679.673679.673616476.768216.710811337.140642.7140.58
INMB11.1 K11.1 K11.1 K11.1 K11.1 K11.1 K11.1 K11.1 K11.1 K11.1 K11.1 K11.1 K8.3 K5.8 K36.7 K33.1 K34.7 K

Werewolf Therapeutics and related stocks such as IO Biotech, Spruce Biosciences Common, and OUTLOOK THERAPEUTICS INC Operating Cycle description

My Equities

My Current Equities and Potential Positions

Werewolf Therapeutics
HOWL
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Business Address200 Talcott Ave,
ExchangeNASDAQ Exchange
USD 0.61
When determining whether Werewolf Therapeutics is a strong investment it is important to analyze Werewolf Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Werewolf Therapeutics' future performance. For an informed investment choice regarding Werewolf Stock, refer to the following important reports:
Check out Werewolf Therapeutics Performance and Werewolf Therapeutics Correlation.
For more information on how to buy Werewolf Stock please use our How to buy in Werewolf Stock guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Werewolf Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Werewolf Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Werewolf Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...